Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL15794084 | 1.00 | CA4 (0.50) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL2945248 | 0.95 | — | — | |
| Bicarbonate SCHEMBL28325836 | 0.95 | CA4 (0.55) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL16166367 | 0.95 | CA1 (0.56) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL9247678 | 0.95 | CA1 (0.56) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL8466588 | 0.95 | CA1 (0.56) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL1263331 | 0.95 | — | — | |
| Bicarbonate SCHEMBL4097336 | 0.90 | CA4 (0.64) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL8025641 | 0.90 | CA1 (0.50) | CA4CA1CA2CA9FAHD1 | |
| Bicarbonate SCHEMBL6032220 | 0.90 | CA4 (0.50) | CA4CA1CA2CA9FAHD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2247596-A2 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI -CANCER AGENTS | Natco Pharma Limited (IN) | 2010-11-10 | — | — | EP | claimed |
| WO-2009098715-A2 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI -CANCER AGENTS | NATCO PHARMA LIMITED (IN) | 2009-08-13 | — | — | WO | claimed |
| US-4859473-A | Process for making low sodium baked crackers | NABISCO BRANDS, INC. (US) | 1989-08-22 | — | — | US | claimed |
| US-12420265-B2 | Cerium-tin-based composite oxide catalyst for catalyzing purification of nitrogen oxide, preparation method and application thereof | RESEARCH CENTER FOR ECO-ENVIRONMENTAL SCINCES, CHINESE ACADEMY OF SCIENCES (CN) | 2025-09-23 | — | — | US | disclosed |
| CN-119301305-A | Circuit board copper chloride etching waste liquid precipitation treatment recycling method and device | 叶涛 | 2025-01-10 | — | — | CN | disclosed |
| US-20230042287-A1 | CERIUM-TIN-BASED COMPOSITE OXIDE CATALYST FOR CATALYZING PURIFICATION OF NITROGEN OXIDE, PREPARATION METHOD AND APPLICATION THEREOF | RESEARCH CENTER FOR ECO-ENVIRONMENTAL SCIENCES, CHINESE ACADEMY OF SCIENCES (CN) | 2023-02-09 | — | — | US | disclosed |
| US-8845759-B2 | Reduction of ammonia smell in substances for oxidative dyeing and/or lightening keratin fibres | HENKEL AG & CO. KGAA (DE) | 2014-09-30 | — | — | US | disclosed |
| US-20140165299-A1 | REDUCTION OF AMMONIA SMELL IN SUBSTANCES FOR OXIDATIVE DYEING AND/OR LIGHTENING KERATIN FIBRES | HENKEL AG & CO. KGAA (DE) | 2014-06-19 | — | — | US | disclosed |
| US-8349847-B2 | Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents | KONAKANCHI DURGA PRASAD (IN) | 2013-01-08 | — | — | US | disclosed |
| US-20100298351-A1 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTS | NATCO PHARMA LIMITED (IN) | 2010-11-25 | — | — | US | disclosed |
| EP-2247596-A2 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI -CANCER AGENTS | Natco Pharma Limited (IN) | 2010-11-10 | — | — | EP | disclosed |
| WO-2009098715-A2 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI -CANCER AGENTS | NATCO PHARMA LIMITED (IN) | 2009-08-13 | — | — | WO | disclosed |
| US-20040033435-A1 | Underlayer of a water-insoluble and alkali-soluble resin; image-recording layer of the resin plus an infrared absorbent; for making a multilayer infrared laser positive-working printing plate | FUJI PHOTO FILM CO., LTD. | 2004-02-19 | — | — | US | disclosed |
| EP-1007517-A1 | PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLTHIAZOLES | Abbott Laboratories (US) | 2000-06-14 | — | — | EP | disclosed |
| US-5959118-A | Process for the preparation of 5-hydroxymethylthiazoles | ABBOTT LABORATORIES (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999011636-A1 | PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLTHIAZOLES | ABBOTT LABORATORIES (US) | 1999-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140165299-A1 | REDUCTION OF AMMONIA SMELL IN SUBSTANCES FOR OXIDATIVE DYEING AND/OR LIGHTENING KERATIN FIBRES | KRT18, OAT, AKR7A2 | CA4 1192/4885CA1 2831/4885CA2 1668/4885 |
| US-20100298351-A1 | NOVEL PYRAZOLO [3, 4 -D] PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTS | DPYD, TYMP, TYMS | CA4 3005/4885CA1 3985/4885CA2 3477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.